Who We Are

Advancing Precision Oncology (APO) | Advancing Pathology Education (APE)

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care

Where oncology, pathology, molecular diagnostics, and emerging science come together to shape the future of cancer care.

APO | APE brings together leading experts and multidisciplinary cancer care professionals through complimentary regional conferences offering accredited continuing education.

Our programs are designed around a simple idea: cancer diagnosis and treatment should not be educated in isolation.

Biomarkers guide therapy. Molecular testing influences treatment decisions. New therapies create new diagnostic needs. Advances in pathology, genomics, and translational science increasingly shape how clinicians understand disease and select treatment.

By bringing these perspectives together, APO | APE connects diagnostic insight with therapeutic action – creating education that reflects how precision cancer care happens in practice.

One Conference. Two Essential Perspectives. One Continuum.

Cancer care is increasingly interconnected.

The specialists identifying and characterizing disease are working alongside the clinicians making treatment decisions. Advances in molecular diagnostics are changing therapeutic strategies, while new treatments are creating new questions for pathology and laboratory medicine.

That is why Advancing Precision Oncology and Advancing Pathology Education come together within one integrated conference experience.

Rather than separating diagnosis from treatment, APO | APE creates a shared educational environment focused on the complete patient journey – from understanding the biology of disease to selecting and delivering individualized treatment.

Where Precision Oncology Meets Pathology

Advancing Precision Oncology | APO

Advancing Precision Oncology explores the rapidly evolving science, clinical evidence, and treatment strategies transforming cancer care.

Educational areas may include:

Targeted therapies
Immunotherapy
Biomarker-driven treatment
Emerging clinical data
Novel therapeutic strategies
Resistance mechanisms
Treatment sequencing
Evolving standards of care
Precision medicine approaches across solid tumors and hematologic malignancies

APO helps clinicians translate rapidly changing evidence into informed, individualized treatment decisions.

Advancing Pathology Education | APE

Advancing Pathology Education focuses on the discoveries, technologies, and diagnostic advances transforming how cancer is identified, characterized, and understood.

Educational areas may include:

Molecular and genomic profiling
Biomarker testing
Next-generation sequencing
Liquid biopsy and ctDNA
Minimal residual disease
Digital pathology
Artificial intelligence
Emerging diagnostic technologies
Integration of pathology and molecular findings into clinical decision-making

APE connects diagnostic innovation with its growing impact on treatment selection and patient management.

Designed for the Multidisciplinary Cancer Care Community

APO | APE programs bring together professionals working across the diagnostic-to-treatment continuum, including:

Oncologists • Hematologists • Pathologists • Hematopathologists • Surgeons • Radiation Oncologists • Advanced Practice Providers • Nurses • Pharmacists • Genetic Counselors • Molecular & Laboratory Professionals • Clinical & Translational Researchers • Fellows & Trainees

Education Without Barriers

The pace of change in cancer care demands continuous learning.

We believe access to high-quality education should not depend on geography, institution, or registration cost. That is why APO | APE conferences are complimentary for qualified healthcare professionals, with accredited continuing education available at no cost to eligible participants.

Our regional programs bring leading faculty, clinically relevant education, and multidisciplinary collaboration closer to the professionals delivering cancer care in communities across the country.